We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for dasatinib (Bristol-Myers Squibb Australia Pty Ltd)
Active ingredients
dasatinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet, film-coated
Indication
For the treatment of paediatric patients with chronic myeloid leukaemia
Therapeutic area
Haematology